Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT03617666Phase 2Unknown
Avelumab in the Frontline Treatment of Advanced Classical Hodgkin Lymphoma - a Window Study
Hodgkin Lymphoma
PrincipalinvestigatorStart date: 2019-09-27
NCT02249429Phase 2Completed
Open-Label, Non Randomized Phase 2 Study With Safety Run-In
Lymphoma, Malignant
PrincipalinvestigatorStart date: 2015-05-01

Research Network

Collaboration Network

12 collaborators·50 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Affiliations

Churchill Hospital

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT03617666Phase 2PrincipalInvestigator

Avelumab in the Frontline Treatment of Advanced Classical Hodgkin Lymphoma - a Window Study

Hodgkin Lymphoma
Unknown
NCT02249429Phase 2PrincipalInvestigator

Open-Label, Non Randomized Phase 2 Study With Safety Run-In

Lymphoma, Malignant
Completed

All 2 trials loaded